Skip to content

Adult Arm of DZL All Age Asthma Cohort (ALLIANCE)

The All Age Asthma Cohort (ALLIANCE) of the German Center for Lung Research (DZL), Adult Arm

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02419274
Acronym
ALLIANCE
Enrollment
400
Registered
2015-04-17
Start date
2014-03-31
Completion date
2030-12-31
Last updated
2023-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

asthma, phenotype, childhood, adulthood

Brief summary

Deep Phenotyping of adult asthma patients: * severity from mild to severe * both atopic and non-atopic * both childhood and adult onset * both smokers and non-smokers * corresponding pediatric cohort (Pediatric Arm of DZL All Age Asthma Cohort) with equivalent SOPs regarding collection of biomaterial and clinical data incl. lung function, further processing of biomaterial and further analyses

Detailed description

The clinical heterogeneity of asthma patients has been increasingly recognised within the last years. Recent studies and articles highlighted the idea of asthma not beeing a single disease but rather a unifying term for multiple phenotypes. Phenotype in this sense is defined as the combination of observable properties of an organism, that are produced by the interactions of a genotype and the environment. In contrast, endotype describes a specific underlying pathophysiological pathway. Linking asthma phenotypes and endotypes in a system biological approach is an important research goal in order to develop targeted therapy, especially for severe asthma. The advantage the investigators' cohort provides is the collaboration with an equivalent pediatric cohort. In this setting questions regarding disease onset, exacerbation and chronicity can be posed and worked with in a comprehensive manner.

Interventions

None listed

Sponsors

German Center for Lung Research
CollaboratorOTHER
Research Center Borstel
CollaboratorOTHER
LungenClinic Grosshansdorf
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* Proven Diagnosis according to current GINA Guideline (2014) * Ability to read and understand German * Ability to understand and agree to informed consent

Exclusion criteria

* History of respiratory tract infection within the last 4 weeks before inclusion

Design outcomes

Primary

MeasureTime frame
Defining clinical asthma phenotypes by combining clinical, lung function and biomaterial data2 years

Countries

Germany

Contacts

Primary ContactThomas J Bahmer, MD
thomas.bahmer@uksh.de+49 4102 601 2412
Backup ContactJoern Bullwinkel, PhD
j.bullwinkel@lungenclinic.de+49 4102 601 2410

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 8, 2026